# Lightship

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lightship

- Industry: Software
- Headquarters: El Segundo, US
- Website: www.lightship.com
- Total disclosed funding: $20M
- Latest round: Series B (Feb 3, 2020)
- Investors on record: 3

## About

Lightship, Inc. is dedicated to transforming clinical research by conducting inclusive, decentralized, and hybrid trials, enhancing patient access and representation within the biopharmaceutical industry.Founded in 2018 and headquartered in El Segundo, US, Lightship, Inc. focuses on creating innovative clinical trial solutions. The company has successfully raised funding, with its most recent round in October 2021 securing USD 40.00 mn from investors including Define Ventures and Khosla Ventures. Founded by Alon Krashinsky, Brian Lovett, and Samantha Eells, the company has notably pivoted towards decentralized and hybrid trial models to better serve diverse populations.Lightship specializes in conducting inclusive decentralized and hybrid clinical trials, aiming to enhance patient access and representation in clinical research. Their core offerings include a community-based clinical trial solution that efficiently facilitates the enrollment of diverse populations across the United States and the United Kingdom. Lightship’s model is designed to overcome geographic and cultural barriers, ensuring that trials are faster and more representative while maintaining high-quality standards. The services encompass outreach and recruitment, decentralized trials, hybrid trials, mobile research units, and mobile nursing services, all tailored to meet the unique needs of biopharmaceutical sponsors, academic institutions, and Contract Research Organizations (CROs). The company primarily serves clients in the biopharmaceutical sector and academic institutions, focusing on the enrollment of traditionally underserved populations, thus broadening participation in clinical research.Lightship generates revenue through service agreements with biopharmaceutical sponsors and academic institutions involved in clinical research. These agreements typically involve a structured pricing model based on project scopes, which may include fees for outreach initiatives, recruitment services, and the operational management of clinical trials. Transactions are structured to provide a comprehensive package that encompasses everything from patient engagement to trial execution and monitoring, ensuring a seamless process for clients. The company’s emphasis on hybrid and decentralized trial models enables them to cater to a wide array of clients seeking efficient and inclusive trial methodologies. Their revenue streams are bolstered by the demand for increased patient retention and diversity in clinical studies, reflecting a growing industry trend towards more representative clinical trial practices.In October 2021, Lightship, Inc. raised USD 40.00 mn in venture funding to accelerate its expansion efforts, including an international presence with a new office set to open in London, United Kingdom, in the fall. The company aims to enhance its offerings with new product developments and to penetrate additional markets, focusing on increasing their operational footprint in Europe and beyond.

## Funding rounds

- Series B, Feb 3, 2020, $20M — Khosla Ventures, McKesson Ventures, Define Ventures

## Investors

- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series B
- McKesson Ventures (https://capitalatlas.ai/funds/mckesson-ventures) — Series B
- Define Ventures (https://capitalatlas.ai/funds/define-ventures) — Series B